Background Covered or uncovered self expandable metallic stents (SEMS) placed in patients with malignant biliary obstruction can occlude in 19-40 %, but optimal management is unclear. Aim We sought to summarize current evidence regarding management of occluded SEMS in patients with malignant biliary obstruction. Methods Two investigators independently searched Pubmed, Embase, and Web of Science using pre-defined search criteria, and reviewed bibliographies of included studies. Data were independently abstracted by two investigators, and analyzed using RevMan. We compared strategies of second SEMS versus plastic stents with respect to the following outcomes: rate of second stent re-occlusion, duration of second stent patency, and survival. Results Ten retrospective studies met inclusion criteria for the systematic review. Management options described were placement of an uncovered SEMS (n = 125), covered SEMS (n = 106), plastic stent (n = 135), percutaneous biliary drain (n = 7), mechanical cleaning (n = 18), or microwave coagulation (n = 7). Relative risk of re-occlusion was not significantly different in patients with second SEMS compared to plastic stents (RR 1.24, 95 % CI 0.92, 1.67, I 2 = 0, p 0.16). Duration of second stent patency was not significantly different between patients who received second SEMS versus plastic stents (weighted mean difference 0.46, 95 % CI -0.30, 1.23, I 2 = 83 %). Survival was not significantly different among patients who received plastic stents versus SEMS (weighted mean difference -1.13, 95 % CI -2.33, 0.07, I
Background
Initial endoscopic placement of a self-expandable metallic stent (SEMS) is associated with longer patency and lower risk of cholangitis compared to conventional polyethylene stents in patients with malignant biliary obstruction [1] [2] [3] [4] [5] . Although SEMS cost more than plastic stents, initial use of a SEMS is a cost-effective approach for patients expected to live longer than 3 months because fewer subsequent endoscopic retrograde cholangiopancreatography (ERCP) procedures are required [4, 5] .
Nonetheless, SEMS is associated with an occlusion rate of 19-40 % which has remained largely unchanged in spite of modifications in stent composition and the addition of a plastic coating [6] [7] [8] [9] [10] [11] . Occlusion is attributed to epithelial hyperplasia, tumor in-growth and overgrowth, dislocation, debris formation, and clot accumulation [1] [2] [3] 12] . Consensus is lacking for the optimal management of occluded SEMS in patients with malignant biliary obstruction.
We conducted a systematic review and meta-analysis to assess the effectiveness of various management approaches. We hypothesized that although second SEMS would be associated with longer patency and lower re-occlusion rate than plastic stents, the patency of second SEMS would be shorter than that reported for the initial SEMS due to reduced life expectancy.
Methods

Search Strategy and Study Selection
Two study investigators (TS, SD) independently searched Pubmed, Embase, and Web of Science in March 2011 for studies evaluating management of occluded SEMS in patients with malignant biliary occlusion. Search criteria were developed a priori in consultation with a health sciences librarian at Duke University Medical Center (Table 1) . Full text of potentially relevant articles were obtained and evaluated for exclusion criteria ( Table 2) . The bibliographies of all relevant articles were hand searched for relevant studies that were not identified on the initial search. Disagreements in study selection were resolved by consensus, or discussion with a third investigator who was a senior advanced endoscopist (MH).
Data Abstraction
Data were independently abstracted by two study investigators (TS, HD) on a Microsoft Excel spreadsheet (XP, Professional edition; Microsoft, Redmond, WA, USA), and reviewed for accuracy by a third investigator (SD). Abstracted outcomes were duration of stent patency (continuous), occurrence of stent re-occlusion (dichotomous outcome), and survival (continuous). We abstracted means and standard deviations of continuous variables when these were available, and calculated these values from medians and ranges (obtained either from the text or Kaplan-Meier curves) when the mean and standard deviation was not reported [11] . We contacted authors to obtain additional information when data were missing for our study outcomes.
Statistical Analysis
Studies that reported management of occluded SEMS with both SEMS and plastic stents were included in the metaanalysis in order to compare pooled outcomes between strategies of second SEMS versus plastic stent placement. All statistical analyses were performed using Review Manager Version 5 (RevMan for Windows 2008, the Nordic Cochrane Center, Copenhagen, Denmark). Outcomes were assessed using a random effects model to give a more conservative estimate of treatment effect that accounted for heterogeneity between studies [10] . Duration of second stent patency and survival using a strategy of second metal stent versus plastic stent were compared using weighted mean differences and 95 % confidence intervals. Rates of re-occlusion with second metal stents versus plastic stents were compared using risk ratios and 95 % confidence intervals. All of the above outcomes were represented graphically using Forest plots.
Heterogeneity across studies for each of these outcomes was assessed using the I 2 statistic, which ranges from 0 to 100 % (0 % represents no heterogeneity and larger values indicate increasing heterogeneity). A value of I 2 \ 50 %, accompanied by a p value of [0.10 for the chi-square test was considered to represent low levels of heterogeneity.
We assessed for publication bias graphically by visual inspection of funnel plot symmetry.
Results
The initial search yielded 1,416 citations in Pubmed, 710 citations in Embase, and 475 citations in Web of Science ( Fig. 1 ). Of the 24 citations initially identified as potentially relevant on Pubmed, nine met inclusion criteria [9, [13] [14] [15] [16] [17] [18] [19] [20] . One additional article was included after performing a bibliography search of the nine included studies [21] . All of the ten potential citations in Embase and 13 potential citations in Web of Science were excluded, since they were either duplicates or abstracts. All of the studies were retrospective ( Table 3 ). The Pubmed search was updated on a monthly basis until February 2012 and no new publications meeting inclusion criteria were found. The ten included studies represented 392 patients with malignant bile duct, hilum, or hepatic duct obstruction and an occluded SEMS. Sample size in individual studies ranged from 13 to 77 patients (Table 4 ). In one of the studies, only patients with distal common bile duct obstruction were included [14] . In another study, patients with hilar obstruction were not included [15] . Pancreatic cancer was the most common cause of biliary obstruction in nine of the ten studies (n = 225). Cholangiocarcinoma and metastatic disease were the second and third most frequently listed malignancies respectively.
The initial occluded stent was an uncovered metal stent in 271 patients and a covered metal stent in 44 patients. Nine of the ten studies commented on cause of initial SEMS occlusion. The most frequently reported cause of initial SEMS occlusion was tumor ingrowth (n = 187) followed by sludge or debris (n = 54) and tumor overgrowth (n = 46). A combination of tumor ingrowth and debris was responsible for initial SEMS occlusion in 25 patients [20] . A combination of tumor ingrowth and overgrowth was reported in nine patients from one study [17] . The type of occluded SEMS was not specified for 77 patients from two studies [15, 19] . The initial stent was placed endoscopically in 224 patients and percutaneously in 25 patients. The route of stent placement was not specified for the remaining 143 patients from four studies [13, 15, 20, 21] . In one study, there were 38 patients with 44 occlusions and outcomes were reported for each occlusion [17] . Initial SEMS diameter was not reported in all studies, but when this information was included, a 10 French diameter stent was most frequently used.
Management options described for occluded SEMS were placement of another uncovered SEMS (n = 125), covered SEMS (n = 106), plastic stent (n = 135), percutaneous biliary drain (n = 7), mechanical cleaning (n = 18), or microwave coagulation (n = 7). The second stent was placed endoscopically in 294 patients and percutaneously in eight patients. Route of stent placement was not specified for 90 patients from two studies [13, 21] . In one of the studies, 21 occluded SEMS and 35 plastic stents were managed with placement of a covered Wallstent [15] . Outcomes among patients with initial plastic and metal stents in this study were pooled, so patency and survival with a covered Wallstent in patients with occluded SEMS alone could not be assessed [15] . None of the studies reported whether or not plastic stents were electively replaced every 2-6 months to pre-empt stent occlusion, as is common practice at many centers.
Outcome: Second Stent Re-Occlusion
The proportion of patients with a second stent occlusion was reported in seven of the eight studies that described both second SEMS and plastic stents for management of SEMS occlusion. In the second SEMS group, 65/190 stents occluded. In the plastic stent group, 56/124 stents occluded. Relative risk of re-occlusion was not significantly different in patients with second SEMS compared to plastic stents (RR 1.24, 95 % CI 0.92-1.67, I 2 = 0, p = 0.16; Fig. 2 ). Funnel plot inspection was not suggestive of significant publication bias (Fig. 3) . Four studies utilized both covered and uncovered SEMS as the second stent [13, 16, 18, 19] . Three of these four studies reported proportion of patients with re-occluded covered and uncovered SEMS [13, 16, 18] . When these three studies were pooled, a strategy of using a covered SEMS compared to an uncovered SEMS as the second stent was not associated with a significantly different re-occlusion rate (RR 1.43, 95 % CI 0.58-3.55, I
2 57 %, p = 0.44).
Outcome (Table 5 ). Mean and standard deviation for duration of second stent patency were reported or calculable in five of the eight studies that described both second SEMS and second plastic stents for management of SEMS occlusion. When the results of these studies were pooled, duration of second stent patency was not significantly different between patients who received second SEMS (n = 157) versus plastic stent (n = 93; weighted mean difference 0.46, 95 % CI -0.30, 1.23, I 2 = 83 %, p = 0.23; Fig. 4 ). Funnel plot inspection was not suggestive of significant publication bias (Fig. 5) . We did not compare duration of stent patency between covered and uncovered SEMS because means and standard deviations were calculable for only two studies that utilized both stent types.
Outcome: Survival
Median survival ranged from 70 to 389 days for uncovered SEMS, 198-440 days for covered SEMS, 90-296 days for plastic stents, and 34-210 days for mechanical cleaning. Mean and standard deviation for survival were reported or calculable in only two of the eight studies that described both second SEMS and second plastic stents for management of SEMS occlusion [13, 14] . When the results of these two studies were pooled, survival was not significantly different among patients who received plastic stents versus second metal SEMS (weighted mean difference -1.13, 95 % CI -2.33, 0.07, I
2 86 %, p = 0.07).
Costs and Cost-Effectiveness
Although our literature search did not identify any formal cost-effectiveness analyses, three of the included studies attempted to address the cost of various strategies for managing SEMS occlusion from the perspective of endoscopic utilization. One study calculated a cost benefit favoring a strategy of plastic stents when compared to All included studies were retrospective chart reviews uncovered SEMS or mechanical cleaning [14] . Another study concluded that the incremental cost-effectiveness of plastic stents and second SEMS was superior to a strategy of mechanical cleaning. This study also concluded that uncovered SEMS were more cost effective than plastic stents when the cost of an ERCP exceeded $1967 [16] . The third study concluded that plastic stents were the most costeffective option for management of occluded SEMS [17] .
Discussion
In patients with malignant biliary obstruction, robust data suggest that the higher cost of an initial SEMS may be mitigated by the reduced need for repeated ERCP [4, 5] . This literature is not infrequently extrapolated in clinical practice as a rationale to place another SEMS in patients with occluded SEMS. Unfortunately, the natural history of patients who develop SEMS occlusion is to have a shorter survival compared to when the stent was initially placed for malignant jaundice. Indeed, in this systematic review median survival ranged from merely 70 to 440 days. Thus, the likelihood of surviving long enough to develop second stent occlusion is significantly lower than with initial stent placement. Our meta-analyses did not reveal significant differences in re-occlusion rates or stent patency between strategies of second SEMS compared to plastic stents. While this study did not directly assess cost-effectiveness, these results suggest that management of occluded SEMS with a plastic stent may be less expensive and equivalently effective.
On the other hand, the range of survival when reported (three studies) was wide, with maximum survival [2 years in one study and [8 years in another. These findings highlight the need to account for a patient's performance status when making decisions regarding second metal versus plastic stent placement.
Exclusion of non-English language studies can potentially bias the estimate of treatment effect. Only one nonEnglish study was identified during the initial search. Inclusion of this article is unlikely to have changed overall study results because initial stent occlusion (plastic and metal) occurred in only 12 patients. Furthermore, the English abstract suggests that this article would have been excluded because the authors describe management of both benign and malignant strictures using initial plastic stents and SEMS [22] .
A limitation of our findings is that all studies were observational in design, and therefore patient assignment to different interventions is subject to selection bias. Indeed, we noted that the percentage of patients who received a second plastic stent in each study included in the metaanalysis varied from 14 to 84 %. An endoscopist's decision to place a plastic, uncovered metal, or covered metal stent is likely to be influenced by the location of the occlusion as well as perception of the patient's performance status. Since a patient with poor perceived performance status is probably more likely to receive a plastic stent, we would expect selection bias to skew re-occlusion rate and patency Fig. 2 Forest plot comparing proportion of patients with re-occluded plastic stents (PS) versus self expandable metal stents (SEMS) Fig. 3 Funnel plot of studies assessing proportion of patients with reoccluded plastic stents (PS) versus self expandable metal stents (SEMS) in favor of second SEMS. However, in our meta-analyses re-occlusion rate and patency were not significantly improved with a strategy of second SEMS. Finally, our results must be interpreted in context of the significant heterogeneity observed between studies for one of the outcomes.
To our knowledge, this is the first study to systematically review the literature regarding optimal management of SEMS occlusion in patients with malignant biliary obstruction. In the absence of randomized controlled trials, our study summarizes the best available information to address this common and difficult clinical scenario. Strengths of the study include the systematic search criteria, independent literature search and abstraction by separate investigators for accuracy, and the application of welldefined statistical methodology to pool results of different studies.
In summary, management of occluded SEMS in patients with malignant biliary obstruction using a strategy of second SEMS does not appear to reduce re-occlusion rates or improve duration of second stent patency when compared to a strategy of plastic stent placement. Prospective studies that account for location of obstruction and performance status in decision making are necessary to more definitively guide management. 
